N4P.L
N4 Pharma Plc [N4P.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
N4P.L Stock Summary
Top 10 Correlated ETFs
N4P.L
Top 10 Correlated Stocks
N4P.L
In the News
N4P.L Financial details
Company Rating
-
Market Cap
1.83M
Income
-2.25M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
07 Mar 2024
P/E
-2.05
Forward P/E
-
PEG
-0.62
P/S
-
P/B
1.01
P/C
-
P/FCF
-3.67
Quick Ratio
24.64
Current Ratio
27.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-35.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
133.33%
-
-
-
-
SMA20
-15.22%
SMA50
-31.58%
SMA100
-37.1%
Inst Own
-
Inst Trans
-
ROA
-48%
ROE
-49%
ROC
-0.57%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.6-2.3
52W High
-
52W Low
-
RSI
52.52
Rel Volume
6.52
Avg Volume
757.58K
Volume
4.94M
Perf Week
13.33%
Perf Month
-10.53%
Perf Quarter
-39.29%
Perf Half Y
-29.17%
-
-
-
-
Beta
-0.026
-
-
Volatility
0.02%, 0.04%
Prev Close
0%
Price
0.425
Change
15.61%
Company Profile
- Volume Average 757.58K
- Market Capitalization 1.83M
- Employee 5
- CEO Mr. Nigel James Theobald
- Headquarters London,GB
- IPO Date 1988-07-01
-
Website
https://www.n4pharma.com 
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
